Flash Finance

Krishna Institute of Medical Sciences LimitedKIMSCorporate

Healthcare Medical Care Facilities Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹685.60
MCap ₹27,434 Cr · P/E 141.1
Krishna Institute of Medical Sciences Limited — Stock analysis & AI research Krishna Institute of Medical Sciences Limited — Multibagger AI analysis Krishna Institute of Medical Sciences Limited — Seasonality — best & worst months Krishna Institute of Medical Sciences Limited — Technical indicators & charts Krishna Institute of Medical Sciences Limited — Technical setup — score, trend, support & resistance Krishna Institute of Medical Sciences Limited — Live exchange announcements
📋 Small Cap Stocks List 📈 Lowest Technical Score 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹1,180 Cr
Sales · Jun 2026
+35.3% YoY
₹223 Cr
Operating Profit · Jun 2026
+15.8% YoY
18.9%
OPM % · Jun 2026
-14.5% YoY
₹37 Cr
Net Profit · Jun 2026
-56.0% YoY
₹1.04
EPS · Jun 2026
-46.9% YoY

📝 Krishna Institute of Medical Sciences Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Krishna Institute of Medical Sciences Limited reported revenue of ₹1,180 crore for the quarter ended June 2026 (Q1 FY27), up 35.3% from ₹872 crore in the same quarter last year, and up 9.7% sequentially over the March 2026 quarter.

Net profit fell 56.0% year-on-year to ₹37 crore, from ₹85 crore. Earnings per share (EPS) came in at ₹1.04.

Operating profit stood at ₹223 crore — an operating margin (OPM) of 18.9%, compared with 22.1% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Krishna Institute of Medical Sciences Limited posted revenue of ₹3,906 crore, a growth of 28.7% over FY25, with a net profit of ₹242 crore (down 41.5% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹4,214 crore with a net profit of ₹194 crore.

Valuation snapshot

At the current price of ₹685.60, KIMS has a market capitalisation of ₹27,434 crore and a trailing P/E of about 141.1.

Within the Medical Care Facilities industry, it is the 8th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 32.50%, foreign institutional investors (FIIs) 14.74%, domestic institutional investors (DIIs) 34.43%, public shareholders 18.33% of Krishna Institute of Medical Sciences Limited.

Promoter holding slipped from 34.11% to 32.50% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹27,434 Cr
Current Price ?
₹685.6
P/E ?
141.12above ind
Industry P/E ?
56.40
P/B ?
12.21
P/S ?
6.51
P/FCF ?
-30.41
Enterprise Value ?
₹31,687 Cr
EV/EBITDA ?
38.07
PEG ?
N/A
Earnings Yield ?
1.6%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹4,214 Cr
OPM ?
19.8%
Profit after tax (TTM) ?
₹194 Cr
EPS (TTM) ?
₹4.86
ROCE ?
9.0%
ROE ?
8.7%
ROA ?
2.5%
Growth
Sales — latest qtr ?
₹1,180 Cr
PAT — latest qtr ?
₹37 Cr
YoY qtr sales growth ?
35.3%
YoY qtr profit growth ?
-56.0%
Sales growth (3y) ?
21%
Sales growth (5y) ?
24%
Profit growth (3y) ?
-9%
Profit growth (5y) ?
4%
Financial Health
Debt ?
₹4,253 Cr
Debt to Equity ?
1.89
Interest Coverage ?
2.6
Current Ratio ?
N/A
Ownership
Promoter holding ?
32.50%
Change in promoter holding ?
-1.61%
Pledged percentage ?
N/A
Market
Return 3 months ?
-14.6%
Return 6 months ?
0.5%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 5625766066526066346887777727978729619981,0751,180 +35.3% +9.7%
Operating Profit 151163157177160159179218187198193204199206223 +15.8% +8.4%
Other Income 653311455184745117 +148.6% +1640.0%
Interest 125991716182026273345576883 +152.7% +22.6%
Depreciation 3335323342463941455353667985101 +90.2% +18.6%
Profit Before Tax 11312711913911210012716213513411497695557 -50.4% +2.9%
Net Profit 829987101827295121921068572523337 -56.0% +13.3%
EPS 9.4911.6510.1011.508.991.642.162.682.222.541.961.671.331.061.04 -46.9% -1.9%
OPM % 26.9% 28.3% 25.9% 27.2% 26.5% 25.1% 26.0% 28.1% 24.2% 24.8% 22.1% 21.2% 19.9% 19.2% 18.9% -14.5% -1.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹3,034 Cr ₹3,906 Cr ₹4,214 Cr +28.7%
Operating Profit ₹782 Cr ₹802 Cr ₹832 Cr +2.5%
OPM % 25.78% 20.53% 19.76% -20.4%
NPM % 13.64% 6.20% 4.61% -54.5%
Other Income ₹32 Cr ₹17 Cr ₹27 Cr -47.7%
Depreciation ₹178 Cr ₹283 Cr ₹331 Cr +59.3%
Interest ₹91 Cr ₹203 Cr ₹253 Cr +124.1%
EBIT ₹604 Cr ₹519 Cr ₹502 Cr -14.1%
PBT ₹558 Cr ₹335 Cr ₹278 Cr -40.0%
Tax ₹69 Cr — ₹19 Cr —
Net Profit ₹414 Cr ₹242 Cr ₹194 Cr -41.5%
EPS ₹9.60 ₹6.02 ₹5.10 -37.3%
Material Cost ₹326 Cr — ₹261 Cr —
Employee Cost ₹253 Cr — ₹213 Cr —
Extraordinary Items ₹11 Cr — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 80808080 +0.0%
Reserves 1,5901,7482,0582,167 +5.3%
Borrowings 6781,3552,5574,253 +66.3%
Other Liabilities 5536369951,258 +26.4%
Total Liabilities 2,9013,8205,6897,759 +36.4%
Fixed Assets 1,7662,4343,3485,710 +70.5%
CWIP 4776001,214606 -50.1%
Investments 6815799103 +4.0%
Other Assets 5906291,0281,339 +30.3%
Total Assets 2,9013,8205,6897,759 +36.4%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 432521582511 -12.2%
Cash from Investing Activity -416-753-1,116-1,452 -30.1%
Cash from Financing Activity 20217543940 +73.1%
Net Cash Flow 36-159-1 -111.1%
Free Cash Flow -140-125-380-902 -137.4%
CFO/OP 87%102%91%83% -8.8%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 42434852 +8.3%
Inventory Days ———44 —
Days Payable ———146 —
Cash Conversion Cycle 424348-50 -204.2%
Working Capital Days 8-5-29-35 -20.7%
ROCE % 24%17%15%9% -40.0%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 34.11%34.11%34.11%34.11%32.50% -4.7%
FIIs 15.54%15.03%14.33%14.57%14.74% +1.2%
DIIs 31.65%32.12%32.72%32.50%34.43% +5.9%
Public 18.68%18.74%18.85%18.82%18.33% -2.6%
No. of Shareholders 1,08,9551,04,8721,01,59993,33394,730 +1.5%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Krishna Institute of Medical Sciences Limited's revenue in Q1 FY27?
Krishna Institute of Medical Sciences Limited reported revenue of ₹1,180 crore for the quarter ended June 2026 (Q1 FY27), up 35.3% from ₹872 crore in the same quarter last year, and up 9.7% sequentially over the March 2026 quarter.
What was Krishna Institute of Medical Sciences Limited's net profit in Q1 FY27?
Net profit fell 56.0% year-on-year to ₹37 crore, from ₹85 crore. Earnings per share (EPS) came in at ₹1.04.
What is KIMS's market capitalisation and P/E ratio?
At the current price of ₹685.60, KIMS has a market capitalisation of ₹27,434 crore and a trailing P/E of about 141.1.
Who owns Krishna Institute of Medical Sciences Limited? (shareholding pattern)
As of Jun 2026, promoters held 32.50%, foreign institutional investors (FIIs) 14.74%, domestic institutional investors (DIIs) 34.43%, public shareholders 18.33% of Krishna Institute of Medical Sciences Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI